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Summary
A series of signal-directed transitions regulates the
development of distinct populations of self-tolerant
B cells and ultimately the production of antibody-
producing plasma cells. We studied the role of calci-
neurin/NFAT signaling in B cells by deleting the regu-
latory b1 subunit of calcineurin specifically in B cells.
Follicular (FO) and marginal zone (MZ) B cells develop
normally in these mice, but B1 cell numbers are re-
duced. In vitro, calcineurin b1-deficient B cells have
a cell-intrinsic proliferation defect downstream of the
B cell receptor. These mice have higher total serum
IgM despite the absence of B1 cells and have en-
hanced T cell-independent-1 responses. Conversely,
mice with calcineurin b1-deficient B cells develop
larger germinal centers and have reduced plasma
cell development and antigen-specific antibody pro-
duction during T cell-dependent immune responses.
By several different criteria, calcineurin is dispensable
for B cell tolerance, indicating that this phosphatase
complex modulates immunogenic, but not tolero-
genic, responses in vivo.
Introduction
The adaptive immune system orchestrates cellular and
humoral responses against diverse pathogens. In order
to initiate responses to such pathogens, B lymphocytes
rely on signaling through a variety of cell surface recep-
tors, which elicit different responses through the induc-
tion of different genetic programs. Depending on the
type of antigen, B cells can respond in the absence or
presence of costimulation from T cells. During T cell-de-
pendent responses, B cell-T cell interactions result in
the expansion of antigen-specific B cells and germinal
center formation. Affinity maturation, class switching,
and ultimately plasma cell formation result from the co-
ordinated actions of multiple immune cell types within
these germinal centers (McHeyzer-Williams et al., 2001).
The relative contributions of downstream signaling
components during these responses are of clinical and
biological interest. Engagement of the B cell receptor
(BCR) activates the Ca2+/calmodulin-dependent ser-
ine-threonine phosphatase calcineurin (Antony et al.,
2004; Choi et al., 1994; Venkataraman et al., 1994). Acti-
*Correspondence: crabtree@stanford.eduvation of calcineurin in lymphocytes has been shown to
dephosphorylate and activate the NFATc transcription
factors (Crabtree and Olson, 2002). B cells express
NFATc1, NFATc2, and NFATc3 (Timmerman et al.,
1997). Mice deficient in NFATc1, NFATc2, and NFATc3
alone and in combination have compromised B cell pro-
liferation in vitro, but the in vivo B cell immune responses
in these mice has not been examined (Peng et al., 2001;
Ranger et al., 1998; Yoshida et al., 1998). Dysregulated T
cell function in these mice makes it difficult to glean the
B cell intrinsic functions of calcineurin/NFAT signaling
in vivo from these studies. The immunosuppressive cal-
cineurin inhibitors cyclosporine A (CsA) and FK506 alter
in vivo B cell responses (Higham et al., 1986; Kunkl and
Klaus, 1980). Again, it is unclear whether these effects
are due to specific inhibition of calcineurin in B cells or
due to the systemic effects of the injected inhibitors.
Signal transduction downstream of the B cell receptor
(BCR) controls responses to both antigenic (foreign an-
tigen) and tolerogenic (self-antigen) stimuli (Jun and
Goodnow, 2003). Constitutive low-level activation of
NFATc1 and NFATc2 was detected in anergic B cells
from BCR transgenic mice (IgHEL) expressing a soluble
neoself-antigen (sHEL), suggesting a role for the calci-
neurin/NFAT pathway in the establishment or mainte-
nance of B cell anergy (Healy et al., 1997). Although ad-
ditional signaling molecules have been implicated in B
cell functional inactivity, no other transcription factors
have been shown to function in the induction of this
state of B cell unresponsiveness (Cornall et al., 1998;
Mecklenbrauker et al., 2002; Rui et al., 2003).
We addressed the B cell autonomous function of the
calcineurin complex by deleting the regulatory subunit
(calcineurin b1, Cnb1) specifically in B cells. We find
that B cells require calcineurin activity, cell autono-
mously, for proliferation after BCR stimulation in vitro.
Interestingly, mice with Cnb1-deficient B cells develop
larger germinal centers during T cell-dependent immune
responses due to a specific requirement for calcineurin
in the differentiation of plasma cells. Our results indicate
that the Ca2+/calcineurin/NFAT pathway is a key regula-
tor of immunogenic B cell responses in vivo and that im-
munosuppressive drugs that inhibit the calcineurin
phosphatase complex dually inhibit T and B lymphocyte
activation without affecting B cell tolerance.
Results
Generation of Mice Lacking Cnb1 Specifically
in B Cells
The active calcineurin phosphatase complex is a hetero-
trimer of a catalytic A subunit (calcineurin Aa, calcineurin
Ab, or calcineurin Ag), a regulatory B subunit (calcineurin
b1 or calcineurin b2), and calmodulin. B cell defects
have not been reported in either CnAa2/2 (Zhang et al.,
1996) or CnAb2/2 (Bueno et al., 2002) mice, likely due
to compensation by the other calcineurin A catalytic
subunit(s). Complete inactivation of calcineurin phos-
phatase activity in somatic tissues can be accomplished
by deletion of Cnb1 (Neilson et al., 2004), as Cnb2 is
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142Figure 1. CD19cre Deletes Cnb1 in Immature B Cells, Resulting in a Complete Loss of Calcineurin Phosphatase Activity
(A) Cnb1 locus is deleted specifically in B cells. FACS-sorted B cells (B220+) and T cells (TCRb+) were analyzed by genomic PCR. Bands corre-
sponding to the Cnb1f and Cnb1D alleles are indicated.
(B) Cnb1 locus is completely deleted in MZ and FO B cells. Cells were sorted as gated in the top panel of Figure 1E. Genomic PCR was used to
analyze the Cnb1 genomic locus.
(C) Cnb1 protein is absent from Cnb1f;CD19cre B cells. Splenic B cells (B220+) and T cells (TCRb+) were analyzed by Western blotting for Cnb1.
Actin shows equal loading.
(D) Dephosphorylation of NFATc1 requires Cnb1 after PMA/Ionomycin stimulation. Actin shows equal loading.
(E) Normal FO and MZ B cells in spleens of Cnb1f;CD19cre mice. B220+ cells are shown. Percentages are the mean 6 SD (n = 7).
(F) B1 cells are reduced in Cnb1f;CD19cre mice. Peritoneal cells (top) or splenocytes (bottom) were gated on forward and size scatter and as in-
dicated. Percentages are the mean 6 SD (n = 3, **p value < 0.01).
(G) Left, normal splenic B cell numbers in Cnb1f;CD19cre mice. Splenic B cell (B220+) subsets were further subdivided as NF (CD212CD232), FO
(CD21+CD23+), and MZ (CD21hiCD23med/lo) as gated in Figure 1E. Graphs show the mean number of cells 6 SD (n = 7). Right, reduced B1 cells
numbers inCnb1f;CD19cre mice. Quantification of peritoneal B1a, B1b, and B2 cells as gated in Figure 1F. Graphs show the mean percent of total
peritoneal cells 6 SD (n = 3; *p value < 0.1,**p value < 0.01).
(H) Normal splenic MZ. Frozen sections of control and Cnb1f;CD19cre spleen were stained and analyzed by confocal microscopy. Marginal zone
(MZ), B cell follicle (FO), and the T cell zone (T) are indicated. MOMA+ cells demarcate the boundary between the B cell follicle and the marginal
zone. Scale bar is 100 mm.expressed specifically in the testis (Ueki et al., 1992).
Mice with a loxP-flanked (floxed) calcineurin b1 (Cnb1)
locus (Neilson et al., 2004) were crossed with the
CD19cre knockin mice (Rickert et al., 1997) to specifically
delete theCnb1 locus in B cells. Deletion of theCnb1 ge-
nomic locus was assessed by PCR using primers that
detect the Cnb1 floxed (Cnb1f) and null (Cnb1D) alleles.
Peripheral B cells, but not T cells, from Cnb1f/D;
CD19cre/+ mice had recombined the Cnb1 genomic lo-
cus, lacked Cnb1 protein and RNA, and did not express
Cnb2 (Figures 1A and 1C and Figure S1A available in the
Supplemental Data with this article online). Deletion of
the Cnb1 locus was assessed in newly formed (NF),
FO, and MZ splenic B cells. Deletion of the Cnb1f allele
was complete in mature FO and MZ B cells, whereas
a low level of NF B cells retained the floxed locus (Fig-
ure 1B and Figure S2).
Calcineurin function was assessed by stimulating pu-
rified B cells with ionomycin and phorbol-myristate-
acetate. In B cells from control mice, NFATc1 was
dephosphorylated after stimulation and dephosphoryla-tion was blocked by the calcineurin inhibitor CsA. Cnb1-
deficient B cells failed to dephosphorylate NFATc1 and
NFATc2 (Figure 1D and data not shown), indicating
that in B cells, Cnb1 is required for calcineurin phospha-
tase activity. Additionally, Cnb1-deficient B cells failed
to upregulate known NFAT transcriptional target genes
(NFATc1 itself and Egr2) after BCR stimulation (Fig-
ure S1B). Collectively, these results indicate that Cnb1-
deficient B cells lack calcineurin activity and NFAT tran-
scriptional activity after stimulation. Cnb1f/f, Cnb1f/D,
Cnb1f/+, Cnb1f/+;CD19cre/+, and Cnb1D/+;CD19cre/+ mice
were comparable in all experiments and will be referred
to collectively as control. Cnb1f/f;CD19cre/+ and Cnb1f/D;
CD19cre/+ mice were also similar in all experiments and
will be referred to collectively as Cnb1f;CD19cre.
Specific Reduction of B1 Cells in the Absence
of Cnb1
Thymocyte-specific deletion of Cnb1 results in a partial
block of pre-TCR-induced differentiation and a complete
block of thymocyte positive selection (Neilson et al.,
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1432004). Cnb1f;CD19cre mice have normal B cell develop-
ment, but these mice do not delete Cnb1 completely
during development (Figure S2). To assess the role of
calcineurin in early stages of B cell development, the
Cnb1flox mice were crossed to the inducible Mx-cre
mouse line (Kuhn et al., 1995). Induction of the Cre re-
combinase in Cnb1f/f;Mx-cre mice led to complete dele-
tion of the Cnb1f alleles and an absence of Cnb1 protein
in bone marrow. B cell development proceeds normally
in mice reconstituted with this Cnb1-deficient bone
marrow (E.M.G., M.M.W., and G.R.C. manuscript in
preparation). Therefore, in contrast to T cell develop-
ment, calcineurin is dispensable for conventional B cell
development. Thus, we focused on the role of the calci-
neurin complex in peripheral B cells from Cnb1f;CD19cre
mice.
Spleens and lymph nodes from control and
Cnb1f;CD19cre mice had comparable total B cell num-
bers (Figures 1E and 1G and data not shown). Control
and Cnb1f;CD19cre B cells expressed similar levels of
CD1d, CD2, CD5, CD9, CD21, CD22, CD25, CD40,
CD69, CD72, CD80, CD86, CD95, CD95L, IgM, and IgD
(Figures 1E and 1F, Figure S2, and data not shown).
The expression of CD23 was slightly higher on MZ B
cells in the absence of Cnb1 (Figure 1E). Additional phe-
notypic analysis indicated that MZ B cells are present in
theCnb1f;CD19cre mice (Figure S3). Additionally, splenic
architecture, including the presence of the MZ, is normal
in Cnb1f;CD19cre mice (Figure 1H and data not shown).
In contrast to conventional B cells, peritoneal B1a
and B1b cells were reduced in Cnb1f;CD19cre mice
(Figure 1F and 1G), consistent with the reduced B1 cell
development fromNFATc1-deficient hematopoetic cells
(Berland and Wortis, 2003). Splenic B1 cells were exam-
ined to determine if there is a general defect in B1 cell
development or a specific defect in peritoneal B1 cell
homing (Ansel et al., 2002). Splenic B1 cells were re-
duced 4-fold in Cnb1f;CD19cre mice (Figure 1F), indicat-
ing that calcineurin is required for the generation or
maintenance of B1 cells. Fetal B cell development has
not yet been analyzed, leaving open the possibility that
calcineurin may be required for early development of
fetal derived B cells.
Cell Autonomous Requirement for Cnb1 after
BCR Signaling
In vitro, B cell stimulation with either cognate antigen or
antibody-mediated crosslinking of the BCR leads to ac-
tivation. Cnb1f;CD19cre;IgHEL B cells were hyporespon-
sive to antigen and anti-IgM stimulation and upregulated
CD86 and CD54 less well than control cells (Figure 2A
and data not shown). Cnb1-deficient B cells also failed
to increase cell size after antibody-mediated BCR cross-
linking (Figure S4). Purified B cells from Cnb1f;CD19cre
mice failed to incorporate [3H]thymidine in response to
anti-IgM, an effect that was mirrored by addition of
CsA to control cells (Figures 2B and 2C). The defect in
BCR-induced [3H]thymidine incorporation was incom-
pletely rescued by the addition of IL-4 and not affected
by increasing the concentration of anti-IgM (Figures 2B
and 2C). Proliferation induced by anti-CD40 alone or in
combination with anti-IgM was partially inhibited, con-
sistent with results using the calcineurin inhibitor CsA
(Figure 2B, data not shown, and Klaus et al. [1994]).The low [3H]thymidine incorporation could be caused
by increased cell death or decreased proliferation.
Spontaneous cell death and cell death induced by re-
ceptor signaling was not altered by the absence of
Cnb1 in vitro (Figure S4). Additionally, in vivo, Cre-medi-
ated deletion of genes required for cell survival often
manifests as apparent poor deletion of the allele (Kraus
et al., 2004; Pasparakis et al., 2002). CD19cre deleted the
Cnb1f allele well (Figures 1A and 1B), and the emergence
of a population of B cells that failed to delete Cnb1 and
preferentially survived in vivo was never observed, indi-
cating that calcineurin is dispensable for B cell survival.
To directly measure proliferation, purified B cells were
labeled with CFSE and the cell division profile was ex-
amined. After anti-IgM stimulation, control B cells un-
derwent several rounds of cell division while Cnb1-defi-
cient B cells did not divide (Figure 2D). To determine if
calcineurin controls the expression of an autocrine/
paracrine growth factor after antigen receptor stimula-
tion, as it does in T cells, control and Cnb1-deficient B
cells were cultured together. Anti-IgM-stimulated
Cnb1f;CD19cre B cells failed to proliferate even when
cocultured with control B cells (Figure 2E), indicating
that the role of calcineurin in BCR-induced proliferation
in vitro is cell intrinsic and is not secondary to produc-
tion of an autocrine/paracrine growth factor.
The inability of Cnb1-deficient B cells to enter S phase
indicates that they either fail to upregulate a gene re-
quired for S phase entry or degrade a cell cycle inhibitor.
Calcineurin-deficient small resting B cells stimulated
with anti-IgM degraded p27kip normally but failed to
phosphorylate Rb on the Cdk4/6 sites (serine 807/811).
Cdk4/6 activity is critically dependent on the up-
regulation of cyclin D2 (Chen-Kiang, 2003), and this
rate-limiting cyclin is not induced in Cnb1-deficient B
cells. This result explains the cell autonomous and abso-
lute requirement for calcineurin in BCR-induced prolifer-
ation (Figure 2F).
Normal B Cell Tolerance in the Absence of Cnb1
Activation of the Ca2+/calcineurin/NFATc signaling path-
way has been shown to correlate with the induction/
maintenance of B cell anergy in the IgHEL;sHEL model
system (Goodnow et al., 1988; Healy et al., 1997). To
test whether Cnb1f;CD19cre mice have a defect in toler-
ance induction or maintenance in a controlled system,
we made bone marrow chimeras, transferring Cnb1f;
IgHEL or Cnb1f;CD19cre;IgHEL bone marrow into lethally
irradiated C57/BL6 or sHEL recipients. Cnb1f;IgHEL or
Cnb1f;CD19cre;IgHEL bone marrow transferred into
C57/BL6 mice developed normally (Figure 3A). B cells
in the bone marrow, lymph nodes, blood, and spleen
of Cnb1f;IgHEL / sHEL mice developed the expected
IgD+IgMloCD5med anergic phenotype (Figure 3A and
data not shown) (Goodnow and Basten, 1989; Goodnow
et al., 1988; Hippen et al., 2000). B cells from Cnb1f;
CD19cre;IgHEL/ sHEL mice also appeared phenotypi-
cally tolerant (Figure 3A). Both Cnb1f;IgHEL / sHEL
andCnb1f;CD19cre;IgHEL/ sHELmice failed to produce
anti-HEL serum immunoglobulin (Figure 3C), indicating
that in the absence of Cnb1, B cells are functionally tol-
erant. Due to the short half-life of anergic B cells (Fulcher
and Basten, 1994), analysis of the Cnb1 genomic locus
and Cnb1 protein level in sorted anergic B cells was
Immunity
144Figure 2. Defective Activation and Proliferation Downstream of the BCR in Cnb1-Deficient Cells
(A) Cnb1-deficient B cells are hyporesponsive to antigen and BCR crosslinking. Results are the mean 6 SD of triplicate cultures.
(B)Cnb1 is required for proliferation. [3H]thymidine incorporation of purified splenic B cells. Concentration in mg/ml is shown in brackets. IL-4 was
used at 40 ng/ml. Results are the mean 6 SD of triplicate cultures.
(C) Neither Cnb1-deficient nor control B cells treated with CsA (100 ng/ml) incorporate [3H]thymidine after BCR crosslinking. Results are the
mean 6 SD of triplicate cultures.
(D) Cnb1-deficient B cells fail to proliferate after in vitro aIgM (10 mg/ml) stimulation as assessed by CFSE dilution.
(E) Coculture of Cnb1f;CD19cre B cells with control B cells does not rescue their defective proliferation after BCR crosslinking. Control cells are
IgDa+, and Cnb1-deficient cells are IgDa2(IgDb+).
(F) Cnb1f;CD19cre B cells fail to upregulate cyclin D2 and phosphorylate Rb after in vitro aIgM (40 mg/ml) stimulation as assessed by Western
blotting. HSP90 shows equal loading.particularly crucial. Anergic B cells from the Cnb1f;
CD19cre;IgHEL / sHEL mice had rearranged the Cnb1
genomic locus and lacked Cnb1 protein (Figure 3B and
data not shown).
Additionally, mice that were genetically Cnb1f;
CD19cre;IgHEL;sHEL were analyzed. These mice devel-
oped phenotypically anergic B cells and did not have de-
tectable titers of serum anti-HEL (data not shown), indi-
cating that the results obtained in the bone marrow
chimera experiments were not skewed by the irradiation
and reconstitution procedure.
Mice with defective B cell tolerance develop autoreac-
tive antibodies and have multiorgan lymphocytic
infiltrates. As a second test of B cell tolerance, 8- to
14-month-old Cnb1f;CD19cre mice were tested for the
presence of autoantibodies. The titer of anti-dsDNA,
anti-RNP, and anti-nuclear antibodies and the level of
circulating immune complexes in control and Cnb1f;
CD19cre mice were not significantly different. Addition-
ally, serum from these mice did not stain Hep2 cells,indicating that anti-nuclear antibodies of other specific-
ities are also absent (Figures 3D and 3E and data not
shown). Consistent with these results, histology of the
kidney, liver, lung, muscle, and salivary gland from 12-
month-old Cnb1f;CD19cre mice did not show any auto-
immune pathology (Figure 3F and data not shown).
Therefore, although calcineurin and NFATc may be acti-
vated by tolerogenic signaling, this pathway is not re-
quired to induce or maintain B cell tolerance in vivo.
Increased Serum IgM in the Absence of Cnb1
Serum IgM levels in Cnb1f;CD19cre mice were w2-fold
higher than in control mice (Figure 4A). However, the se-
rum profile did not resemble classic hyper-IgM syn-
drome, as the IgG isotypes were not reduced (Figure 4A).
The increase in serum IgM in Cnb1f;CD19cre mice could
either be dependent on BCR specificity and activation
of a subset of B cells or be independent of BCR specific-
ity. To address these possibilities, we analyzed Cnb1f;
CD19cre mice expressing the BCR transgene specific
Calcineurin b1-Deficient B Cell Responses
145Figure 3. Cnb1 Is Dispensable for B Cell Anergy In Vivo
(A) Bone marrow chimeras were constructed as indicated and analyzed for phenotypic changes associated with anergy (IgD+;IgMlo) after recon-
stitution. Percentages are expressed as the mean 6 SD (n = 3).
(B) Cnb1 protein is absent in anergic Cnb1f;CD19cre B cells. B220+ cells were sorted from Cnb1f/D;IgHEL/ sHEL and Cnb1f/D;CD19cre;IgHEL/
sHEL mice. Actin shows loading.
(C) Relative serum anti-HEL titers from bone marrow chimeras. Each dot represents an individual mouse.
(D) 8- to 14-month-old Cnb1f;CD19cre mice do not develop significant levels of serum anti-dsDNA antibodies. 14-week-old MRL/lpr is shown as
a positive control, and the dilutions are indicated in the brackets. Squares represent female mice, circles represent male mice, and the horizontal
line represents the mean (ns, not significant).
(E) Serum from old female Cnb1f;CD19cre mice does not stain Hep2 cells. 14-week-old MRL/lpr is shown as a positive control, and the dilutions
are indicated in the brackets.
(F) Normal kidney and salivary gland histological structure in 12-month-old female Cnb1f;CD19cre mice. Sections were stained with H&E (n = 2).
Scale bar is 200 mm.for hen egg lysozyme (IgHEL; [Goodnow et al., 1988]). In-
creased serum IgM was present in Cnb1f;CD19cre;IgHEL
mice, was more dramatic in older mice, and was also
present in mice reconstituted with Cnb1f;CD19cre;IgHEL
bone marrow (Figures 4B and 3C). The observation
that mice with a defined BCR specificity still develop in-
creased serum IgM in the absence of their cognate anti-
gen indicates that the increase in serum IgM is unlikely
to be driven by antigenic stimulation through the BCR.
Cnb1 Negatively Regulates T Cell-Independent
Type 1 Immune Responses
To understand what leads to the increased IgM in
Cnb1f;CD19cre mice, we investigated the immune re-
sponses to T cell-independent (TI) and T cell-dependent(TD) antigens. Cnb1f;CD19cre mice immunized with the
TI type 1 antigen TNP-LPS, producedw3-fold higher ti-
ters of TNP-specific IgM, and had an increased number
of IgM forming cells (Figure 4C and data not shown).
Consistent with previous data, wild-type mice treated
with the calcineurin inhibitor FK506 also have enhanced
IgM response to TNP-LPS, indicating that calcineurin is
required at the time of immunization to negatively regu-
late the TI-1 response (Figure 4D and Higham et al.
[1986] and Kunkl and Klaus [1980]). Collectively, our ge-
netic and pharmacologic results indicate that calci-
neurin is required cell autonomously in B cells to nega-
tively regulate their response to TI-1 antigens.
A simple explanation of these results would be that
Cnb1-deficient B cells either proliferate more or produce
Immunity
146Figure 4. Cnb1f;CD19cre Mice Have In-
creased Total Serum IgM and TI-1 Responses
(A) Increased serum IgM but normal IgG in
Cnb1f;CD19cre mice. Serum Ig was deter-
mined by ELISA and is plotted as concentra-
tion relative to isotype controls. Each circle
represents an individual mouse, and the hor-
izontal bar shows the mean (***p value <
0.001).
(B) Increased serum anti-HEL titer in
Cnb1f;CD19cre;IgHEL mice. Serum anti-HEL ti-
ter in IgHEL andCnb1f;CD19cre;IgHEL mice was
determined by anti-HEL-specific ELISA and
is plotted as relative anti-HEL titer. Each cir-
cle represents an individual mouse, and the
horizontal bar shows the mean (*p value <
0.02).
(C) Increased IgM response after TI-1 immu-
nization (TNP-LPS) as assessed by TNP-spe-
cific ELISA. Titer is shown as 1/EC50. Days
after immunization are indicated on the bot-
tom of each graph. Each circle represents
an individual mouse, and the horizontal bar
shows the mean (ns, not significant; *p value <
0.05).
(D) FK506 treatment increases LPS re-
sponses. Titer is shown as 1/EC50. Days after
immunization are indicated on the bottom of
the graph. Each square represents an individ-
ual mouse, and the horizontal bar shows the
mean (ns, not significant; **p value < 0.01).
(E) Cnb1-deficient B cells proliferate normally
in response to LPS in vitro. Purified splenic B
cells were stimulated with various LPS con-
centrations, and [3H] thymidine incorporation
was measured. Results are the mean6 SD of
triplicate cultures.
(F) Cnb1-deficient B cells produce comparable levels of IgM after in vitro LPS simulation. Results are the mean 6 SD of triplicate cultures.
(G) Impaired antiphosphorylcholine (PC) responses in Cnb1f;CD19cre mice. Anti-PC and T15 idiotype (Id) titer is shown. Days after immunization
are indicated on the bottom of each graph. Each circle represents an individual mouse, and the horizontal bar shows the mean (ns, not significant;
*p value < 0.05, **p value < 0.01).more IgM after LPS stimulation. Control and Cnb1f;
CD19cre B cells stimulated in vitro with LPS or TNP-
LPS proliferated comparably, had a similar percentage
of CD138+ cells, and produced equivalent titers of IgM
(Figures 4E, 4F, and 2B and data not shown). FACS-
sorted control and Cnb1-deficient MZ B cells also prolif-
erated comparably to LPS in vitro (data not shown).
Therefore, we conclude that calcineurin activity limits B
cell responses to TI-1 antigens only in the context of
the in vivo microenvironment. The increased IgM re-
sponse after TI-1 immunization is consistent with the
increased total serum IgM in Cnb1f;CD19cre mice (Fig-
ure 4A) and may be responsible for the specific increase
in this immunoglobin isotype. Cnb1f;CD19cre mice im-
munized with the T cell-independent type 2 (TI-2) antigen
TNP-Ficoll responded comparably to control mice, al-
though the response was slightly dampened (Figure S5).
In gene-targeted animals, peritoneal B1 cell number
usually correlates with IgM serum levels (Figure S6),
consistent with B1 cells being the major producers of
serum IgM (Hayakawa et al., 1999). Thus, the increase
in serum IgM, despite the apparent decrease in B1 cells
in Cnb1f;CD19cre mice, is paradoxical. To confirm that
peritoneal B1 cells were decreased in the Cnb1f;CD19cre
mice, we immunized these mice with phosphorylcho-
line-KLH (PC-KLH). This antigen elicits a response witha dominance of the T15 idiotype (T15 Id), which is pro-
duced predominantly by B1 cells (Kearney et al., 1981;
Kenny et al., 1983). PC-KLH-immunized Cnb1f;CD19cre
mice produce a lower anti-PC titer and have a dramati-
cally reduced T15 Id titer (Figure 4G). These results are
consistent with the reduced B1 cells in Cnb1f;CD19cre
mice and indicate that the apparent decrease in B1 cells
detected by flow cytometry was not due, in some way, to
altered expression of the markers used to identify these
cells.
B Cell Autonomous Requirement for Cnb1 during
T Cell-Dependent Immune Responses
Mice and humans treated with the immunosuppressive
calcineurin inhibitors CsA and FK506/tacrolimus mount
poor TD immune responses, at least in part due to the in-
hibition of calcineurin in T cells. To dissect the role of
Cnb1 in B cells during TD responses, mice were immu-
nized with sheep red blood cells (SRBC) and with the
hapten antigen TNP-KLH in Complete Freund’s Adju-
vant (CFA). Immunization with TD antigens drives the
formation of germinal centers. Cnb1f;CD19cre mice
immunized with SRBC had a greater percent of germi-
nal center B cells (IgD2CD19+GL7+) after immunization,
as assessed by flow cytometry at 8 days (3.2% 6
0.5% for control and 6.8% 6 1.2% for Cnb1f;CD19cre,
Calcineurin b1-Deficient B Cell Responses
147Figure 5. Larger Germinal Centers in Cnb1f;CD19cre Mice
(A) Increased percentage of GC B cells in SRBC-immunizedCnb1f;CD19cre mice. Lower histograms show GL7 staining on CD19+IgD2 cells (black
line) and naive CD19+IgD+ (shaded gray). Percentages are the mean 6 SD (n = 3).
(B) Increased PNA+ GC size in the spleens of SRBC-immunized Cnb1f;CD19cre mice. Upper scale bar is 500 mm. Lower scale bar is 100 mm.
(C) Quantification of GC number and size in SRBC-immunized mice. Mean 6 SD of four mice per group and 40–90 GC/mouse (*p value < 0.05).
(D) GC B cells from Cnb1f;CD19cre mice lack Cnb1. Naı¨ve (CD19+IgD+) and GC (CD19+IgD2GL7+) B cells were sorted and analyzed by genomic
PCR for Cnb1+, Cnb1f, and Cnb1D alleles.
(E) Comparable proliferation of GC B cells in Cnb1f;CD19cre mice as assessed by BrdU incorporation 8 days after SRBC immunization. Percent-
ages are the mean 6 SD (n = 3).
(F) Comparable cell death of GC B cells in Cnb1f;CD19cre mice as assessed by FITC-VAD-FMK staining, AnnexinV binding (AnnV), and TUNEL
staining 8 days after SRBC immunization. Percentages are the mean 6 SD (n = 3).
(G) Cnb1 is not required for GC B cell class switching. CD95+GL7+ cells were stained for cell surface IgG. Percentages are the mean6 SD (n = 3) 8
days after SRBC immunization.p value < 0.01 and Figure 5A) and 12 days (0.31% 6
0.09% for control and 0.84% 6 0.15% for Cnb1f;
CD19cre, p value < 0.01). Surprisingly, the average size
of the individual germinal centers (GCs) was 2-fold larger
in SRBC-immunized Cnb1f;CD19cre mice, though con-
trol and Cnb1f;CD19cre mice developed the same num-
ber of GCs (Figures 5B and 5C and Figure S7).
Because Cre-mediated deletion is never 100%, we
investigated whether the GC B cells from the Cnb1f;
CD19cre mice arose from a small population of B cells
that failed to delete the Cnb1 allele and were therefore
able to differentiate into GC B cells. The emergence of
the undeleted (Cnb1f) allele was not detected in sorted
GC B cells (Figure 5D), and GC B cells from the SRBC-
immunized Cnb1f/D;CD19cre mice expressed very little
Cnb1 protein (Figure 6H). Collectively, these results indi-
cate that Cnb1 deficiency does not impair the activation
and expansion of antigen-specific B cells during a TD
immune response. Unimmunized mice often have
a small percent of GC B cells due to ongoing immune re-
sponses to minor infections. Consistent with the SRBC
result, unimmunized Cnb1f;CD19cre mice had more GC
B cells than control mice (Figure S7).
Germinal center size is regulated by proliferation, cell
death, and selection into the plasma and memory B cell
compartments. GC B cells from SRBC immunized con-trol and Cnb1f;CD19cre mice incorporated BrdU compa-
rably, indicating that GC B cell proliferation is not
affected by Cnb1 deficiency (Figure 5E). Terminal deoxy-
nucleotidyl transferase nick end labeling (TUNEL)
staining of spleen sections indicated that the number
of TUNEL+ nuclei within the GCs was comparable,
many of which were already phagocytosed (data not
shown). Apoptotic cells are cleared quickly within the
GC, therefore, early cell death markers were carefully
analyzed. The percent of GC B cells that had active cas-
pases (FITC-VAD-FMK+; Figure 5F), had lost the ability
to maintain phosphotidylserine on the inner leaflet of
the cell membrane (Annexin V+; Figure 6F), and had be-
gan cleaving their DNA (TUNEL+; Figure 6F) was not di-
minished inCnb1-deficient GC B cells. This is consistent
with the comparable survival of naive and activated B
cells in vivo and in vitro (Figures 1A–1C and Figure S4).
To determine whether class switching required calci-
neurin, the percent of GC B cells expressing cell surface
IgG was analyzed. SRBC-immunized control and Cnb1f;
CD19cre mice had similar percentages of IgG1, IgG2a/b,
and IgG3 expressing GC B cells, indicating that class
switching is not dramatically affected in the Cnb1-defi-
cient B cells (Figure 5G).
To analyze the responses to a defined antigen, con-
trol and Cnb1f;CD19cre mice were immunized with
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(A) Impaired IgM and IgG responses after T cell-dependent immunization (TNP-KLH). Days after primary immunization are indicated at the bot-
tom of each graph. Mice were given a secondary immunization on day 42 and reanalyzed 5 days later (5m). Each circle represents an individual
mouse, and the horizontal bar shows the mean (ns, not significant; *p value < 0.05, **p value < 0.01, and ***p value < 0.001).
(B) Normal affinity maturation ofCnb1-deficient B cell response. The normalized ratio of high-affinity:total anti-TNP titers is shown as the mean6
SD (n > 4).
(C) Cnb1 is not required for GC B cell class switching. CD95+GL7+ cells were stained for cell surface IgG. Percentages are the mean6 SD (n = 3)
8 days after TNP-KLH immunization.
(D) Plasma cell formation 8 days after primary immunization requiresCnb1. Percentages on the FACS plots are mean6 SD (n = 3, *p value < 0.07).
Graph shows the mean percent of total splenocytes with the PC phenotype 6 SD (n = 3, **p value < 0.02).
(E) Decreased CD138+ cells after CD40 crosslinking of Cnb1-deficient B cells in vitro. Numbers in brackets are the concentration of aCD40 in
mg/ml. Cells were stimulated for 3 days in the presence or absence of CsA (100 ng/ml).
(F) Pharmacologic induction of IRF4 in purified B cells requires both ionomycin (Ion) and phorbol-myristate-acetate (PMA) and is blocked by CsA
(100 ng/ml). Cells were stimulated for 12 hr. HSP90 shows equal loading.
(G) IRF4 is induced rapidly after PMA/Ion stimulation of B cells in vitro. HSP90 shows equal loading.
(H) Cnb1-deficient GC B cells have impaired IRF4 induction. Naive and GC B cells from SRBC-immunized Cnb1f;CD19cre mice (sorted as in
Figure 5A) lack Cnb1 protein expression and have reduced IRF4. HSP90 shows equal loading.TNP-KLH/CFA.Cnb1f;CD19cre mice produced less TNP-
specific IgM and IgG after the primary immunization
(Figure 6A). There was a general decrease in the anti-
gen-specific response, although IgG isotypes were
more significantly affected than IgM. Mice were chal-
lenged with a second immunization to assess their abil-
ity to mount a memory response. Cnb1f;CD19cre mice
produced a lower absolute titer of anti-TNP antibodies,
but the fold increase after secondary immunization
was comparable with control. Additionally, affinity mat-
uration of the antibody responses was comparable in
control andCnb1f;CD19cre mice (Figure 6B). Mice immu-
nized with KLH/CFA did not develop a high anti-TNP ti-
ter, solidifying the antigen specificity of the response to
TNP-KLH/CFA (Figure S5).
To analyze class switching at a single cell level, cell sur-
face expression of distinct IgG isotypes on GC B cells was
determined. Although this flow cytometric analysis does
not exclusively detect TNP-specific B cells, it indicates
that class switching in general is unaffected by the ab-
sence of calcineurin (Figure 6C). These results are consis-
tent with the IgM and IgG anti-TNP titers and the resultsfrom SRBC-immunized mice (Figures 6A and 5G). Also
consistent with the SRBC immunization, TNP-KLH-immu-
nizedCnb1f;CD19cremicehavecomparable GCBcellpro-
liferation and cell death and larger germinal centers
(Figure S8). Cnb1f;CD19cre mice immunized with TNP-
KLH in Incomplete Freund’s Adjuvent instead of CFA
also mounted a less robust response than control mice
(data not shown).
Plasma cell (PC) numbers were 2-fold less in the
Cnb1f;CD19cre mice after TNP-KLH/CFA immunization,
whichcorrelatedwith thedecreasedanti-TNPtiter (Figures
6D and 6A and Figure S8). To determine if the defect in PC
formation is due to a primary B cell intrinsic requirement for
calcineurin, control andCnb1-deficient B cells were stimu-
lated ex vivo with anti-CD40. Fewer B cells from Cnb1f;
CD19cre mice expressed the plasma cell marker CD138/
syndecan-1 after CD40 crosslinking (Figure 6E). Addition-
ally, treatment of control cells with the calcineurin inhibitor
CsA recapitulates the decrease in CD138+ cells observed
with Cnb1-deficient B cells (Figure 6E).
These results are consistent with a block in PC differ-
entiation leading to a larger GC, as has been reported in
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The complexity of cell surface receptors that activate B cells distinguishes them from T cells, and our studies implicate calcineurin in modulating
a distinct set of B cell responses. B cell tolerance and survival are not affected by the absence of Cnb1. During TD immune responses, Cnb1 is
dispensable for class switching, affinity maturation, and secondary responses. In Cnb1f;CD19cre mice B1 cell development, in vitro proliferation
and TD plasma cell differentiation are selectively decreased whereas TI-1 responses in vivo are increased.mice with Blimp-deficient B cells and in p18INK4c-defi-
cient mice (Shapiro-Shelef et al., 2003; Tourigny et al.,
2002). Cnb1 deficiency did not affect GC B cell prolifer-
ation or apoptosis, indicating that the major defect may
be in the regulation of a genetic program that drives
proper terminal differentiation (Figures 5E and 5F and
Figure S8). The transcription factor IRF4 is critical for
PC formation, but the regulation of IRF4 expression in
B cells during TD immune responses is not well charac-
terized (Calame et al., 2003; Mittrucker et al., 1997).
Induction of IRF4 requires both Ca2+ ionophore and
phorbol ester-induced signals, and the induction of
IRF4 by pharmacological stimulation, BCR crosslinking,
or CD40 signaling was reduced in Cnb1-deficient cells
and control cells treated with CsA (Figure 6F and data
not shown). These results indicate that calcineurin activ-
ity is required for proper IRF4 induction. IRF4 may be in-
duced directly by calcineurin/NFAT signaling, as in-
creased IRF4 protein can be detected after 1 hr of
pharmacological stimulation (Figure 6G) and the mouse
Irf4 promoter contains several consensus NFAT binding
sites. Importantly, calcineurin/NFAT signaling appears
to be critical for proper regulation of IRF4 expression
in GC B cells, as the expression of IRF4 in GC B cells
in vivo is reduced in Cnb1f;CD19cre mice (Figure 6H).
Discussion
Biochemical, pharmacological, and genetic experi-
ments have elucidated the role of the calcineurin phos-
phatase complex and the NFATc family of transcription
factors in T cell development and function (Neilson et al.,
2004; Peng et al., 2001; Ranger et al., 1998; Yoshida
et al., 1998). The role of calcineurin and NFAT in B cells,
although recognized, has been less well investigated
(Antony et al., 2004; Choi et al., 1994; Kincaid et al.,
1987; Venkataraman et al., 1994; Verweij et al., 1990).
Our paper is particularly focused on the role of the calci-
neurin signaling pathway in regulating the responses to
the diverse stimuli that B cells receive during their devel-
opment and life in the periphery (Figure 7).
Calcineurin Regulates B Cell Proliferation
through Cyclin D2
Deletion of the regulatory Cnb1 subunit specifically in B
cells abolishes NFATc dephosphorylation and leads tochanges in proliferation and immunogenic responses.
Calcineurin/NFAT signaling controls the transcription
of genes that are cell autonomously required for prolifer-
ation. The inability of anti-IgM-stimulated Cnb1-defi-
cient B cells to upregulate cyclin D2 is sufficient to ex-
plain the G1 arrest, although additional genes are likely
controlled by calcineurin/NFAT in B cells (Figure 3E)
(Glynne et al., 2000). Cyclin D2 induction has been previ-
ously shown to require Ca2+ influx, and calcineurin likely
represents this Ca2+-regulated component (Glassford
et al., 2001, 2003).
Whereas proliferation induced by BCR crosslinking
in vitro is calcineurin dependent, the in vivo responses
of Cnb1f;CD19cre mice are at least partially calcineurin
independent. Anti-IgM ligation in vitro is a good measure
of the ability of the B cells to proliferate to a very well-de-
fined signal through a single cell surface receptor. In vivo
responses to TI-2 and TD antigens are much more com-
plex. TI-2 responses are influenced by complement
receptor coligation and depend on supportive cytokines
from T cells. The full range of cytokines and cell surface
receptors that influence TD responses are still being un-
covered. Fundamentally, our results indicate that the
complexity of cell surface receptor signals that B cells
receive in vivo allow B cell responses to be partially in-
dependent of calcineurin activity.
Increase in Serum IgM in the Absence of B1 Cells
B1 cells are selected on self-antigen, and therefore, the
lack of B1 cell ‘‘positive selection’’ in the absence of
Cnb1 parallels the requirement for calcineurin during
thymocyte positive selection (Hayakawa et al., 1999;
Neilson et al., 2004). The direct correlation between B1
cell number and serum IgM concentration in other
gene-targeted mice is quite striking. In contrast,
Cnb1f;CD19cre mice have greatly reduced B1a and B1b
cell numbers but increased serum IgM.
Calcineurin Does Not Influence B Cell Tolerance
Our in vivo results indicate that calcineurin is dispens-
able for B cell anergy with respect to phenotypic
changes and functional inactivity. B cell tolerance to
the model-antigen hen egg lysozyme was not compro-
mised by the absence of calcineurin (Figure 4). Several
additional observations support this conclusion. If
even a small number of B cells in the Cnb1f/D;CD19cre;
Immunity
150IgHEL/ sHEL mice failed to be anergized, these B cells
would be expected to accumulate in the periphery due
to their longer half-life (Fulcher and Basten, 1994). B
cells from mice that had been reconstituted for 8 months
still had a uniform anergic phenotype, and these mice
did not have significant serum anti-HEL titers (data not
shown). In addition to our genetic experiments, when
calcineurin function was inhibited pharmacologically
by treating mice with CsA, B cell tolerance in the IgHEL;
sHEL system was not compromised (Jason Cyster, per-
sonal communication).
Our results do not entirely rule out a potential role for the
calcineurin/NFAT pathway in regulating anergic B cell
half-life or the ability of these anergic B cells to survive in
a competitive environment. However, when adoptively
transferred into sHEL recipients, Cnb1-deficient IgHEL B
cells were follicularly excluded comparably to control
cells (data not shown) and follicular exclusion occurred
when IgHEL B cells were transferred into CsA-treated
sHEL recipients (Jason Cyster, personal communication).
The observation that Cnb1f;CD19cre mice do not develop
any autoimmune pathology indicates that other B cell tol-
erance checkpoints also do not require calcineurin.
Our interest in the role of calcineurin in B cell anergy
sprouted from the observation that CsA-treated animals
develop autoimmune diseases and that anergic B cells
have nuclear NFAT (Healy et al., 1997; Prud’homme
and Vanier, 1993). Although anergic B cells have con-
stant low-level Ca2+ oscillations, they also fail to have
a sustained Ca2+ flux after antigenic stimulation (Healy
et al., 1997; Hippen et al., 2000). Therefore, B cell anergy
may be determined in part by an inability to activate cal-
cineurin after BCR stimulation, leading to hyporespon-
siveness and a lack of proliferation (Cooke et al., 1994;
Hippen et al., 2000; Mecklenbrauker et al., 2002). The
mechanisms that lead to a refractory state with respect
to a rise in [Ca2+]i in B cells may be particularly important
to the induction of B cell nonresponsiveness.
A role for calcineurin/NFAT signaling in T cell anergy
was shown some time ago (Schwartz, 1996), and elegant
in vitro experiments support this hypothesis (Heiss-
meyer et al., 2004; Macian et al., 2002). Although B cell
and T cell anergy both lead to nonresponsive states,
the cellular response to tolerization is quite different.
Our data indicate that calcineurin is dispensable for B
cell anergy, further mechanistically dividing the driving
forces behind B and T lymphocyte tolerance.
Cnb1 Is Required for TD Immune Responses
B cells require calcineurin cell autonomously for proper T
cell-dependent immune responses. Signaling within the
germinal center downstream of the BCR and/or CD40
may influence the fate of the GC B cells by modulating
NFAT transcriptional activity (Choi et al., 1994; Klaus
et al., 1994; Venkataraman et al., 1994). Calcineurin is re-
quired for proper PC formation both in vivo and in vitro, in
a manner that is dedicated to TD immune responses, as
TI-1 responses are greater and TI-2 responses in
Cnb1f;CD19cremice are comparable to control mice (Fig-
ures 4–6, and Figure S5). The presence of antigen-spe-
cific IgM and IgG after immunization of Cnb1f;CD19cre
mice indicates that calcineurin is not absolutely required
for the development of functional PCs but rather is re-
quired for the proper scope of the response.Our results show that the initiation of the GC reaction
is occurring and that B cells are receiving and respond-
ing to signals, which lead to proliferation, class switch-
ing, and affinity maturation. Nonetheless, these cells
have a reduced capacity to become PCs. The increase
in germinal center size in SRBC- and TNP-KLH-immu-
nized Cnb1f;CD19cre mice is quite striking and is likely
due to the reduced ability of Cnb1-deficient B cells to
differentiate into PCs, thereby decreasing the number
of cells that leave the GC.
A small percentage of GC B cells express IRF4 and
Blimp, and these pre-PCs likely represent GC B cells
that have been selected to differentiate into antibody
forming cells (Angelin-Duclos et al., 2000; Calame
et al., 2003). Irf4-deficient mice have extremely low se-
rum Ig titers due to the inability to form PCs (Mittrucker
et al., 1997). Irf4 expression may be regulated by differ-
ent signal transduction pathways after activation of dif-
ferent cell surface receptors and require the contingent
signaling of several pathways (Pernis, 2002; Sharma
et al., 2002). IRF4 induction downstream of BCR signal-
ing requires c-rel and may be negatively regulated by
MITF in some circumstances (Grumont and Gerondakis,
2000; Lin et al., 2004). The requirement for calcineurin for
the proper induction of IRF4 correlates with the reduc-
tion in PCs in Cnb1f;CD19cre mice. Collectively, our find-
ings indicate that the calcineurin/NFAT signaling path-
way is strictly dedicated to modulating immunogenic,
but not tolerogenic, B cell responses.
Experimental Procedures
Mice
Mice with loxP-flanked calcineurin b1 allele (Neilson et al., 2004)
were crossed with CD19cre knockin mice (Rickert et al., 1997). IgHEL
(MD4; [Goodnow et al., 1988]) and sHEL (ML5; [Goodnow et al.,
1988]) mice were used to assess B cell anergy. Mice were housed
in the Stanford University Research Animal Facility under patho-
gen-free conditions, and experiments were performed in accor-
dance with institutional and national guidelines.
Cell Isolation, Flow Cytometry, and Protein Analysis
For the analysis of the Cnb1 genomic locus, Cnb1 protein, and
mRNA expression, cells were sorted with a FACStarPLUS cell sorter
with B and T cell purities of >98%. Cnb1 genomic locus was as-
sessed by PCR as described (Neilson et al., 2004). For all other stud-
ies, B cells were enriched with negative selection of CD43+ cells (Mil-
tenyi) or B cell negative selection cocktail (Stem Cell) with B cell
purity of >90%. Antibodies against CD1d, CD5, CD9, CD21, CD22,
CD23, CD43, CD54, CD86, CD95, CD95L, CD138, B220, IgD, IgDa,
IgG1, IgG2a/b, IgG3, IgM, IgMa, and GL7 were from BD Pharmingen.
Western blots were performed with antibodies to Cnb1 (Sigma), ac-
tin (Sigma), NFATc1 (7A6; Pharmingen), Egr2/Krox20 (Covance),
HSP90 (Pharmingen), and IRF4 (M-17; Santa Cruz). For proliferation
studies, enriched B cells were stimulated with anti-IgM Fab2 (Jack-
son Immunoresearch), anti-CD40 (Pharmingen), IL-4 (Peprotech),
anti-RP105 (Pharmingen), or LPS (026:B6; Sigma). CFSE labeling
was performed as previously described (Valdez et al., 2002). Serum
immunoglobulin levels were determined by ELISA and were com-
pared to titrated isotype standards. For cell cycle analysis, small
resting B cells were purified (Do et al., 2000) and stimulated with
40 mg/ml anti-IgM. Antibodies to cyclin D2 (M-20; Santa Cruz), pRb
(9308; serine 807/811; Cell Signaling), and p27 (C-19; Santa Cruz)
were used.
Bone Marrow Chimeras
Sex-matched 6- to 8-week-old C57/BL6 or sHEL recipients were le-
thally irradiated with two doses of 450 rad X irradiation, then 23 106
total bone marrow cells from Cnb1f/D;IgHEL or Cnbf/D;CD19cre/+;IgHEL
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mented with neomycin (1.1 g/L). Mice were analyzed 6–30 weeks af-
ter reconstitution. Anti-HEL titer was determined by ELISA; data are
expressed relative to a standard pool of IgHEL serum. IgG anti-
dsDNA levels were determined by ELISA (Alpha Diagnostics).
Immunizations and ELISAs
Immunizations were performed on age- and sex-matched mice,
which were tail bled on day 0 before immunization and on subse-
quent days as indicated. Mice were injected i.p. with 50 mg TNP-
LPS (TI-2), 50 mg LPS (TI-1; Sigma), 50 mg TNP-Ficoll (TI-2), 50 mg
PC-KLH in CFA (B1 cell response), 50 mg KLH (TD control) in CFA,
or 50 mg TNP-KLH (TD) in CFA (DIFCO) on day 0 and 50 mg TNP-
KLH in IFA on day 42. All immunogens were from Biosearch Technol-
ogies except where indicated. Anti-TNP titer is expressed as 1/dilu-
tion that gave half-maximal absorbance. Affinity maturation is ex-
pressed as the normalized ratio of the total anti-TNP titer (highly
haptenated, TNP38BSA) to the high-affinity titer (lowly haptenated,
TNP3BSA). Anti-PC and T15 Id titer was determined as previously
described (Ansel et al., 2002) by using PC-BSA (Biosearch Technol-
ogies) and the anti-T15 antibody AB1.2 (Kearney et al., 1981) with the
PC-specific T15 Id+ antibody BH8 as a standard.
GC Quantitation and Analysis
Naı¨ve and germinal center B cells were sorted on day 8 after ip im-
munization with SRBCs (Colorado Serum Company) as described
(Allen et al., 2004) for Cnb1 genomic PCR and Cnb1 and IRF4 West-
ern blotting. GC size and number was quantified with Image J soft-
ware. BrdU+ cells were quantified with the BrdU-staining kit (BD
Pharmingen). Apoptotic GC B cells were detected with FITC-VAD-
FMK (Promega), AnnexinV (Pharmingen), and TUNEL (Roche).
Histology and Immunoflourescence
Seven-micron sections of OCT flash-frozen spleens from unimmu-
nized and SRBC-immunized mice were used for analysis of splenic
architecture and GC staining, respectively. B220 (BD Pharmingen)
and MOMA (Serotec) were stained to reveal the MZ. PNA-bio/SA-
HRP and DAB substrate (Vector) were used to stain germinal cen-
ters. Hematoxylin and eosin (H&E) staining was performed on paraf-
fin sections.
Supplemental Data
Supplemental Data include eight figures and can be found with this
article online at http://www.immunity.com/cgi/content/full/24/2/
141/DC1/.
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